YIELD GROWTH Signs Letter of Intent with Apothecary

New Post Public Reply Private Reply Replies (0) Message Board
nlightn
183
YIELD GROWTH Signs Letter of Intent with Apothecary Botanicals to Manufacture and Distribute Yield's New Line of Cannabis-Infused Topicals, Jack n Jane, in Canada
Thu October 17, 2019

Vancouver, British Columbia--(Newsfile Corp. - October 17, 2019) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce that it has signed a non-binding letter of intent to enter into a co-packing agreement with Apothecary Botanicals, a Canadian licensed cannabis producer and subsidiary of Geyser Brands Inc. (TSXV: GYSR), for the production and launch of Yield Growth's Canadian Cannabis brand Jack n Jane, a line of cannabis-infused products including tinctures, topicals and capsules.

48846_yield1.jpg


Jack n Jane is Yield Growth's New Line of Cannabis-Infused Topicals

This announcement coincides with Health Canada's official legalization of the production and sale of cannabis extracts and cannabis topicals effective today, marking the one-year anniversary of the legalization of recreational marijuana in Canada.

Yield Growth will engage Apothecary Botanicals to manufacture and distribute its Jack n Jane products in British Columbia, combining Yield Growth's proprietary formulations with Apothecary Botanicals' cannabis supply, services, facilities, equipment and required Health Canada licenses for processing and sales. Yield Growth will supply all non-cannabis ingredients, packaging, and design while Apothecary Botanicals will supply cannabis containing THC and/or CBD as required for the various product formulations. The first phase of production is expected to include three tinctures containing THC and CBD, with a goal of coming to market by December 31, 2019.

Yield Growth intends to incorporate many of the products in its catalogue into the Jack n Jane line, including its own proprietary hemp root oil as a key ingredient and many other high-quality botanicals. The product line currently includes CBD and THC tinctures, muscle and joint gel, massage oils, muscle balm, and foot cream, with several new products in development including transdermal patches and bath soaks.

"Ancient Ayurveda apothecaries worked diligently over millennia to unlock the vast potential of this medicinal plant," says Penny White, CEO of Yield Growth. "We are looking forward to bringing the highest quality skin care and personal care products to Canada with an LP in our beautiful home city of Vancouver."

David Eto, CEO of Apothecary Botanicals, commented, "We are pleased to offer our services to Yield Growth. Our co-packing and manufacturing capabilities combined with our Health Canada approved Licensed Production Facility will support Yield Growth's goal of entering the Canadian market."

According to a report by Deloitte, "edibles, topicals and infused beverages are poised to be the hot new cannabis products." Deloitte estimates that the Canadian market for edibles and alternative cannabis products to be worth C$2.7 billion annually. The report states that 53% of surveyed likely Canadian cannabis consumers are eager to try topicals.

About Geyser Brands Inc.
Geyser Brands Inc. (TSXV: GYSR) is a consumer health and wellness company operating within the Canadian cannabis industry. Geyser’s proprietary delivery technologies include all natural nano-technology, slow-release mechanisms, and non-molecule degrading baking processes. The company provides expertise from conceptual innovation to manufacturing and end-use distribution. Geyser owns a suite of several brands within the consumer-packaged goods market that are offered nationwide at many recognized retailers. Geyser Brands owns a Health Canada approved Licensed Production Facility and operates 15,000 sqft of manufacturing space in two GMP facilities near Vancouver, BC. For more information, visit www.geyserbrands.com.

About The Yield Growth Corp.

The Yield Growth Corp. is building and operating hemp, cannabis and edible mushroom assets and owns wellness brands Urban Juve, Wright & Well, Jack n Jane and Flourish Mushrooms. It has a catalogue of over 200 proprietary beauty, wellness, edibles and beverage formulas at various stages of commercialization. It has filed 12 patents to protect its extraction method and formulas. Urban Juve hemp powered skin care products have been featured in British Vogue, Vanity Fair UK and Elle Canada and Urban Juve has an alliance with leading online beauty community, ipsy. Wright & Well is launching a THC/CBD line of topical products in Oregon and a CBD from hemp topicals line in California this fall. Yield Growth plans to launch a line of edible mushroom wellness products in 2020. Yield Growth is building international distribution channels and has multiple revenue streams including services, licensing and product sales.

For more information about Yield Growth, visit www.yieldgrowth.com or follow @yieldgrowth on Instagram. Visit www.urbanjuve.com and #findyourjuve across social platforms to learn, engage and shop.
Investor Relations Contacts:

Penny White, President & CEO
Kristina Pillon, Investor Relations
invest@yieldgrowth.com

1-833-514-BOSS 1-833-514-2677
1-833-515-BOSS 1-833-515-2677

https://seekingalpha.com/pr/17665403-yield-gr...s-new-line

Better Plant Sciences Inc. (VEGGD) Stock Research Links

VEGGD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 1

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 1

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 1

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 1

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 0

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading

Top 5 Most Recently Viewed Articles

Compass Therapeutics Pursues Growth with New Public Offering

Updated Category News Views 134

Compass Therapeutics Initiates Public Offering Compass Therapeutics, Inc. (NASDAQ: CMPX), a dynamic and innovative biopharmaceutical company at the forefront of developing antibody-based therapies for cancer treatment, has announced the initiation of an underwritten public offering. This move aims to bolster its financial foundation to facilitate the advancement of its...

Continue Reading
Whirlpool Corporation Declares Substantial Quarterly Dividend

Updated Category News Views 312

Whirlpool Corporation Announces Quarterly Dividend Today, the board of directors of Whirlpool Corporation has declared a quarterly dividend of $1.75 per share on the Company's common stock. This dividend showcases the company's commitment to returning value to its shareholders. It will be payable on June 15, 2025, to stockholders of record at the close of business on May...

Continue Reading
How Tastytrade and Zerohash Transformed Account Funding

Updated Category News Views 312

Tastytrade Enables Instant Stablecoin Funding for Traders Tastytrade, the innovative online brokerage firm designed specifically for self-directed investors, has taken a significant leap forward in enhancing the trading experience. By partnering with Zerohash, they have rolled out an advanced stablecoin account funding option. This cutting-edge method allows traders...

Continue Reading
AKVA Group ASA's Strategic Buyback Program for Shares

Updated Category News Views 155

AKVA Group ASA Initiates Share Buyback Program In a recent announcement, AKVA Group ASA has taken a significant step towards enhancing its shareholder value by initiating a buyback program for up to 60,000 of its own shares. This strategic move is part of the company's plan to reinvest in its workforce through an employee share program, thereby fostering a stronger...

Continue Reading
Nvidia Stock: A Buying Opportunity Amid Market Fluctuations

Updated Category News Views 125

Nvidia Stock Sees Pre-Market Decline Shares of Nvidia Corporation (NASDAQ: NVDA) experienced a decline of 2.01% during the pre-market trading session. This drop followed the company's announcement that it had no revenue from H20 chip sales in China. This news has created some concerns among investors, although industry analysts see potential in the current situation....

Continue Reading